McKessonRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
McKessonLargest US pharmaceutical distributor by revenue, with oncology and specialty provider platforms alongside core wholesale. Management attributes much of recent revenue growth to GLP-1 adoption plus branded pharmaceutical demand, though the products carry thin distribution margins.
2021-Q2-2026-Q1
2021-Q2-2026-Q1
1995-2026
$MCK
Largest US drug distributor by revenue. Management ties much of recent revenue growth to GLP-1 adoption alongside branded pharmaceutical demand. The economics are volume without margin: GLP-1s inflate reported revenue at thin distribution spreads.